書籍詳細

参考文献

P.145 掲載の参考文献

• Abend, S. M. and Porder, M. S.:Identification in the neuroses. Int. J. Psychoanal. 67:201-208, 1986
  pubmed

• Adams, P. B. and Weissman, M. M.:Panic disorder and suicide attempts based on best estimate diagnoses of relatives. (submitted for publication)

• Agras, S.:Imipramine and exposure in the treatment of panic disorder with agoraphobia. In:Paper presented the Symposium on Pharmacological and Psychological Approaches to Panic Disorder, Goteborg, Sweden, January, 1990

• Alexander, P. E. and Alexander, D. D.:Alprazolam treatment for panic disorders. J. Clin. Psychiatry 47:301-304, 1986
  pubmed

• Allgulander, C. and Lavori, P.:Excess mortality among 3302 patients with "pure" anxiety neurosis. Arch. Gen. Psychiatry 48:47-52, 1991

• American Psychiatric Association:In:Diagnostic and Statistical Manual of Mental Disorders, 2nd Edition. American Psychiatric Association, Washington, DC, 1968

• American Psychiatric Association:In:Diagnostic and Statistical Manual of Mental Disorders, 3rd Edition. American Psychiatric Association, Washington, DC, 1980

• American Psychiatric Association:In:Diagnostic and Statistical Manual of Mental Disorders, 3rd Edition, Revised. American Psychiatric Association, Washington, DC, 1987

• Andersch, S., Rosenberg, N. K., Kullingslo, H. et al.:Efficacy and safety of alprazolam, imipramine, and placebo in treating panic disorder:a Scandinavian multicenter study. Acta Psychiatr. Scand. 365:18-27, 1991

• Angst, J., Vollrath, M., Merikangas, K. R. et al.:Comorbidity of anxiety and depression in the Zurich cohort sutdy of young adults. In:Comorbidity of Mood and Anxiety Disorders. eds. by Maser, J. D. and Cloninger, R. C., American Psychiatric Press, Washington, DC, 1987, pp 123-137

• Arnow, B. A., Taylor, C. B., Agras, W. S. et al.:Enhancing agoraphobia treatment outcome by changing couple communication patterns. Behav. Ther. 16:452-467, 1985

• Aronson, T. A. and Craig, T. J.:Cocaine precipitation of panic disorder. Am. J. Psychiatry 143:643-645, 1986
  pubmed

• Aronson, T. and Logue, C.:On the longitudinal course of panic disorder:developmental history and predictors of phobic complications. Compr. Psychiatry 28 (4):344-355, 1987

• Arrindell, W., Emmelkamp, P., Monsma, A. et al.:The role of perceived parental rearing practices in the aetiology of phobic disorders:a controlled study. Br. J. Psychiatry 143:183-187, 1983
  pubmed

• Ashton, H.:Benzodiazepine withdrawal:an unfinished story. Br. Med. J. 288:1135-1140, 1984

• Ballenger, I. C.:Pharmacotherapy of the panic disorders. J. Clin. Psychiatry 47:27-32, 1986

• Ballenger, J. C.:Drug treatment strategies:dosage and duration. In:Paper presented at the symposium on Panic Disorder:Strategies for Long-Term Treatment at the annual meeting of the American Psychiatric Association, New York, May, 1990

• Ballenger, J. C.:Long-term pharmacologic treatment of panic disorder. J. Clin. Psychiatry 52 (suppl. 2):18-23, 1991

• Ballenger, J. C., Sheehan, D. and Jacobson, G.:Antidepressant treatment of severe phobic anxiety. Sci. Proc. Am. Psychiatic. Association 130:103-104, 1977

• Ballenger, J. C., Peterson, G. A. and Laraia, C.:A study of plasma catecholamines in agoraphobia and the relationship of serum tricyclic levers to treatment response. In:Biology of Agoraphobia. ed. by Ballenger, J. C., American Psychiatric Press, Washington, 1984, p. 42

• Ballenger, J. C., Howell, E. F., Laraia, M. et al.:Comparison of four medecines in panic disorder. In:Paper presented at the 140th annual meeting of the American Psychiatric Association, Chicago, IL, May, 1987

• Ballenger, J. C., Burrows, G., DuPont, R. et al.:Alprazolam in panic disorder and agoraphobia:results from a multicenter trial, I:efficacy in short-term treatment. Arch. Gen. Psychiatry 45:413-422, 1988
  pubmed

• Balter, M. B., Manheimer, D. I., Mellinger, G. D. et al.:A cross-national comparison of anti-anxiety sedative use. current medical research opinion. JAMA 8 (suppl.):5, 1984

• Bant, W.:Diazepam withdrawal symptoms. Br. Med. J. 4:285, 1975
  pubmed

• Barbaccia, M. C., Coste, E., Ferrero, P. et al.:Diazepam binding inhibitor. Arch. Gen. Psychiatry 43:1143-1147, 1985

• Barlow, D. H.:In:Anxiety and Its Disorders. Guilford Press, New York, 1988

• Barlow, D. H. and Graske, M. G.:Mastery your anxiety and panic. Albany, Graywind Publications, NY, 1989

• Barlow, D. H., O'Brien. G. T. and Last, C. G.:Couples treatment of agoraphobia. Behav. Ther. 15:41-58, 1984

• Barlow, D. H., Craske, M. G., Cerny, J. A. et al.:Behavioral treatment of panic disorder. Behav. Ther. 20:261-282, 1989

• Beaconsfield, P., Ginsburg, J. and Rainbury, R.:Marijuana smoking:cardiovascular effects in man and possible mechanisms. N. Engl. J. Med. 287:209-212, 1972

• Beaudry, P., Fontaine, R., Chouinard, G. et al.:An open clinical trial of clonazepam in the treatment of patients with recurrent panic attacks. Prog. Neuropsychopharmacol. Biol. Psychiatry 9:589-592, 1985
  pubmed

• Beaumont, G.:A large open multicenter trial of clomipramine (anafranil) in the management of phobic disorders.J. Int. Med. Res. 5:116ff, 1977
  pubmed

• Bech, P.:Quality of life in psychosomatic research. Psychopathology 20:169-179, 1987
  pubmed

• Bech, P.:Measurement of psychological distress and well-being. Psychother. Psychosom. 54:77-89, 1990
  pubmed

• Bech, P.:Measuring quality of life:the medical perspective. Nord. J. Psychiatry 46:85-89, 1992

• Bech, P. and Hjortso, S.:Problems in measuring quality of life in schizophrenia. Nord. Psykiatr. Tidsskr. 44:77-79, 1990

• Beck, A. T., Epstein, N., Brown, G. et al.:An inventory for measuring clinical anxiety. J. Consult. Clin. Psychol. 56:893-897, 1988
  pubmed

• Beck, A. T., Steer, R. A., Sanderson, W. C. et al.:Panic disorder and suicidal ideation and behavior:discrepant findings in psychiatric outpatients. Am. J. Psychiatry 148:1195-1199, 1991
  pubmed

• Beck, A. T., Sokol, L., Clark, D. A. et al.:A crossover study of focused cognitive therapy of panic disorder. Am. J. Psychiatry 149:778-783, 1992
  pubmed

• Beitman, B., Basha, I., Flaker, G. et al.:Major depression in cardiology chest pain patients without coronary artery disease and with panic disorder. J. Affect. Disord. 13:51-59, 1987
  pubmed

• Beitman, B., Mukerji, V., Kushner, M. et al.:Validating studies for panic disorder in patients with angiographically normal coronary arteries. Med. Clin. North. Am. 75:1143-1155, 1991
  pubmed

• Bernstein, D. A. and Borkovec, T. D.:In:Progressive Relaxation Training. Champaign, IL, Research Press, 1973

• Biederman, J.:Psychiatric correlates of behavioral inhibition in young children of parents with and without psychiatric disorders. Arch. Gen. Psychiatry 47:21-26, 1990
  pubmed

• Blair, R., Gilroy, J. M. and Pilkington, F.:Some observations on outpatient psychotherapy with a follow-up of 235 cases. Br. Med. J. 1:318-321, 1957
  pubmed

• Bland, R. C., Newman, S. C. and Orn, H.:Epidemiology of psychiatric disorders in Edmonton. Acta. Psychiatr. Scand. 77 (suppl. 338):7-80, 1988

• Bowden, C. L. and Fisher, J. G.:Safety and efficacy of long-term diazepam therapy. South. Med. J. 73:1581-1584, 1980

• Bercher, M.:Review and evaluation of clinical data original NDA 19-906 (pending) clomipramine (Anafranil). Summit, NJ, Ciba Geigy Co, 1989

• Brier, A., Charney, D. and Heninger, G.:Major depression in patients with agoraphobia and panic disorder. Arch. Gen. Psychiatry 41:1129-1135, 1984

• Brier, A., Charney, D. and Heninger, G.:The diagnostic validity of anxiey disorders and their relationship to depressive illness. Am. J. Psychiatry 142:787-797, 1985

• Brier, A., Charney, D. S. and Heninger, G. R.:Agoraphobia with panic attacks:development, diagnostic stability, and course of illness. Arch. Gen. Psychiatry. 45:423-428, 1986

• Britton, K. T., Page, M., Baldwin, H. et al.:Anxiolytic activity of steroid anesthetic alphaxalone. J. Pharmacol. Exp. Ther. 258:124-129, 1991
  pubmed

• Brown, T. A. and Barlow, D. H.:Panic disorder and panic disorder with agoraphobia. In:Principles and Practice of Relapse Prevention. ed. by Wilson, P. H., Guilfordk, New York, pp.191-212

• Brown, T. A., Hertz, R. M. and Barlow, D. H.:New developments in cognitivebehavioral treatment of anxiety disorders. In:American Psychiatric Press Review of Psychiatry, Vol. 11. ed. by Tasman, A., American Psychiatric Press, Washington, DC, 1992

• Burrows, G. D.:Managing long-term therapy for panic disorder. J. Clin. Psychiatry 51:9-11, 1990a

• Burrows, G. D.:Long-term treatment of panic disorder. In:Paper presented at the Symposium on Panic and Anxiety:A Decade of Progress, Geneva, Switzerland, June 21, 1990b

• Clum, G. A.:Psychological interventions vs. drugs in the treatment of panic. Behav. Ther. 20:429-457, 1989

• Cohen, M. E., White, P. D. and Johnson, R. E.:Neurocirculatory asthenia, anxiety neurosis or the effort syndrome. Arch. Intern. Med. 81:260, 1948
  pubmed

• Cohn, J. B. and Wilcox, C. S.:Long-term comparison of alprasolam, lorazepam and placebo in patients with an anxiety disorder. Pharmacotherapy 4:93-98, 1984

• Coryell, W., Endicott, J., Andreasen, N. et. al.:Depression and panic attacks:the significance of overlap as reflected in follow-up and family study data. Am. J. Psychiatry 145:293-300, 1988

• Coryell, W., Noyes, R. J. and Reich, J.:The prognostic significance of HPA axis disturbance in panic disorder:a three-year follow-up. Biol. Psychiatry, 29:96-102, 1991

• Cote, G., Gauthier, J. G., Laberge, B. et al:Clinic-based vs. home-based treatment with minimal therapist contact for panic disorder. In:Paper presented at the meeting of the Association for Advancement of Behavior Therapy, San Francisco, CA, November 1990

• Craske, M. G., Brown, T. A. and Barlow, D. H.:Behavioral treatment of panic:a two-year follow-up. Behav. Ther. 22:289-304, 1991

• Greed, F. and Guthrie, E.:Psychological treatments of the irritable bowel syndrome:a review. Gut 30:1601-1609, 1989

• Crowe, R. R.:Molecular genetics and panic disorder. In:Neurobiology of Panic Disorder. ed. by Ballenger, J., Wiley-Liss, New York, 1991, pp. 59-70

• Crowe, R. R., Noyes, R. Jr., Pauls, D. L. et al.:A family sutdy of panic disorder. Arch. Gen. Psychiatry 40:1065-1069, 1983

• Crowe, R. R, Noyes, R. Jr., Wilson, A. F. et al.:A linkage study of panic disorder. Arch. Gen. Psychiatry 44:933-937, 1987
  pubmed

• Curtis, G. C., Massana, J., Udina, C. et al.:Maintenance drug therapy of panic disorder. In:Paper presented at the 143rd annual meeting of the American Psychiatric Association, New York, May, 1990

• DaCosta, J. M.:On irritable heart:a clinical sutdy of a functional cardiac disorder and its consequences. Am. J. Med. Sci. 61:17-52, 1871

• Deltito, J. A., Argyle, N. and Klerman, G. L.:Patients with panic disorder unaccompanied by depression improve with alprazolam and imipramine treatment. J. Clin. Psychiatry 52:121-127, 1991
  pubmed

• Den Boer, J. A. and Westenberg, H. G.:Effect of a serotonin and noradernaline uptake inhibitor in panic disorders:a double-blind comparison study with fluvoxamine and maprotiline. Int. Clin. Psychopharmacol. 3:59-74, 1988

• Den Boer, J. A. and Westenberg, H. G.:Serotonin function in panic disorder:a double-blind placebo controlled study with fluvoxamine and ritanserin. Psychopharmacology (Berl.) 102:85-94, 1990a

• Den Boer, J. A. and Westenberg, H. G.:Behavioral, neuroendocrine, and biochemical effects of 5-hydroxytryptophan administration in panic disorder. Psychiatr. Res 31:267-278, 1990b

• Den Boer, J. A., Westenberg, H. G. M., Kamerbeek, W. D. et al.:Effect of serotonin uptake inhibitors in anxiety disorders:a double-blind comparison of clomipra-mine and fluvoxamine. Int. Clin. Psychopharmacol. 2:21-32, 1987

• Derogatis, L. R., Lipman, R. S., Rickels, K. et al.:The Hopkins Symptom Checklist (HSCL):a self-report symptom inventory. Behav. Sci. 19:1-15, 1974

• De Ruiter, C., Rijken, H., Garssen, B. et al.:Breathing retraining, exposure, and a combination of both in the treatment of panic disorder with agoraphobia. Behav. Res. Ther. 27:647-655, 1989

• Dirks, J., Schraa, J., Brown, E. et al.:Psycho maintenance in asthma:hospitalization rates and financial impact. Br. Med. Psychol. 53:349-354, 1980
  pubmed

• Dupont, R. L., Swinson, R. P., Ballenger, J. C. et al.:Discontinuation of alprazolam after long-term treatment of panic-relate disorders. J. Clin. Psychopharmacol. 12:352-354, 1992

• Dupont, R. L., Swinson, R. P., Ballenger, J. C. et al.:Discontinuation effects of alprazolam:follow-up of long-term treatment of panic-related disorders. In:Report from the Cross-National Collaborative Panic Study (first phase). (submi.)

• Ehlers, a., Margraf, J., Roth, W. et al.:Anxiety induced by false heart rate feedback in patients with panic disorder. Behav. Res. Ther. 26:1-11, 1988
  pubmed

• Eitinger, L.:Studies in neuroses. Acta. Psychiatr. Neurol. Scand. 30 (suppl. 101):5, 1955

• Endicott, J. and Spitzer, R. L:A diagnostic interview:The Schedule for Affective Disorders and Schizophrenia. Arch. Gen. Psychiatry 35:837-844, 1978
  pubmed

• Evans, L., Kennedy, J., Schneide, P. et al.:Selective serotonin uptake inhibitor in agoraphobia with panic attacks:a double-blind comparison of zimeldine, imipramine, and placebo. Acta. Psychiatr. Scand. 73:49-53, 1986

• Fabre, L. F., McLendon, D. M. and Stephens, A. G.:Comparison of the therapeutic effect, tolerance and safety of ketazolam and diazepam administered for six months to outpatients with chronic anxiety neurosis. J. Int. Med. Res. 9:191-198, 1981
  pubmed

• Faravelli, C.:Life events preceding the onset of panic disorder. J. Affect. Disord. 9:103-105, 1985
  pubmed

• Faravelli, C., Degl'Innocenti, B. G. and Giardinelli, L.:Epidemiology of anxiety disorders in Florence. Acta. Psychiatr. Scand. 79:308-312, 1989

• Fava, G. A. Grandi, S. and Canestrari, R.:Prodromal symptoms in panic disorder with agoraphobia. Am. J. Psychiatry 145:1564-1567, 1988
  pubmed

• Feighner, J. P., Robins, E., Guze, S. B. et al.:Diagnostic criteria for use in psychiatric research. Arch. Gen. Psychiatry 26:57-63, 1972
  pubmed

• Feinstein, A. R.:The pre-therapeutic classification of comorbidity in chronic disease. J. Chronic. Dis. 23:455-468, 1970
  pubmed

• Fink, M., Klein, D. F. and Kramer, J. C.:Clinical efficacy of chlorpromazine-procyclidine combination, imipramine and placebo in depressive disorders. Psycho-pharmacologia 7:27-36, 1965

• Foulds, G. A. and Hope, K.:In:Manual of the Symptom-Sign Inventory. University of London Press, London, England, 1968

• Frank, E., Kupfer, D. J., Perel, J. M. et al.:Three-year outcomes for maintenance therapies in recurrent depression. Arch. Gen. Psychiatry 47:1093-1099, 1989

• Freud, S.:Obsessions and phobias:their psychical mechanisms and their aetiology (1895). In:Collected Papers, Vol. 1., Translated and ed. by Strachey, J., Hogarth Press, London, England, 1940

• Freud, S.:Hemmung, Symptom and Angst (1926). In:Gesammelte Werke XIV. Imago Publishing, London, England, 1948, pp. 111-206

• Freud, S.:On the grounds for detaching a particular syndrome from neurasthenia under the description "anxiety neurosis", In:Standard Edition of the Complete Psychological Works of Sigmund Freud, Vol. 3. Hogarth Press, London, England, 1962

• Freud, S.:Mourning and melancholia (1917). In:The Standard Edition of the Complete Psychological Works of Sigmund Freud. Vol. 14. Translated and ed. by Strachey, J., Hogarth Press, London, England, 1963

• Friedel, R. O.:The therapeutic value, limitations and hazards of treatment of psychiatric disorders with benzodiazepines. In:Handbook of Anxiety, Vol. 1, Biological, Clinical and cultural Perspectives. eds. by Roth, M., Noyes, R. Jr. and Burrows, G. D., Elsevier, Amsterdam, Netherlands. 1988, pp. 385-397

• Fyer, A. J.:Effects of disontinuation of antipanic medication. In:Panic and Phobias 2. eds. by Hand, I. and Wittchen, H. U., Springer-Verlag, New York, 1986, pp. 47-53

• Fyer, M., Uy, J., Martinez, J. et al.:CO2 challenge of patients with panic disorder. Am. J., Psychiatry 144:1080-1082, 1987a

• Fyer, A. J., Liebowitz, M. R., Gorman, J. M. et al.:Discontinuation of alprazolam treatment in panic patients. Am. J. Psychiatry 144:303-308, 1987b

• Gitlin, B., Martin, J., Shear, M. K. et al.:Behavior therapy for panic disorder. J. Nerv. Ment. Dis. 173:742-743, 1985
  pubmed

• Gloger, S., Grunhaus, L., Birmacher, B. et al.:Treatment of spontaneous panic attacks with clomipramine. Am. J. Psychiatry 138:1215-1217, 1981
  pubmed

• Goodwin, G. M., DeSouza, R. J. and Green, A. R.:Presynaptic serotonin receptor-mediated response in mice attenuated by antidepressant drugs and electro-convulsive shock. Nature 317:531-533, 1985

• Gray, J. A.:In:The Neuropsychology of Anxiety. Oxford University Press, Oxford, England, 1982

• Greenhouse, J. B., Stangl, D, Kupfer, D. J. et al.:Methodologic issuses in maintenance therapy clinical trials. Arch. Gen. Psychiatry 48:313-318, 1991

• Griez, E. and Van den Hout, M. A.:CO2 inhalation in the treatment of panic attacks. Behav. Res. Ther. 24:145-150, 1986
  pubmed

• Griffiths, R. R. and Roache, J. D.:Abuse liability of benzodiazepines:a review of human studies evaluating subjects and/or reinforcing effects. In:Benzodiazepines:Standard Use in Clinical Practice. eds. by Smith, D. C. and Wesson, D. R., MTP Press, Boston, MA, 1985, pp. 209-226

• Gross, A. J.:Observations on long-term administration of lorazepam in anxiety states. an open comparison with diazepam. Curr. Ther. Res,22:597-604, 1977

• Grunhaus, L., Hares, Y., Krugler, T. et al.:Major depressive disorder and panic disorder. effects of comorbidity on treatment outcome with antidepressant medications. Clin. Neuropharmacol. 11:454-461, 1988

• Hand, I., Lamontagne, Y. and Marks, I. M.:Group exposure (flooding) in vivo for agoraphobics. Br. J. Psychiatry 124:588-602, 1974
  pubmed

• Harding, T.:Clomipramine (Anafranil) in agoraphobia. J. Int. Med. Res. 1:425, 1973

• Harris, A.:The prognosis of anxiety states. Br. Med. J. 2:649, 1938
  pubmed

• Harris, E. L., Noyes, R. Jr., Crowe, R. R. et al.:A family study of agoraphobia. Arch. Gen. Psychiatry 40:1061-1064, 1983

• Hasin, D., Grant, B. and Endicott, J.:Treated and untreated suicide attempts in substance abuse patients. J. Nerv. Ment. Dis. 176:289-294, 1988
  pubmed

• Henauer, S., Gillespie, M. and Hollister, L.:Yohimbine and the model anxiety state. J. Clin. Psychiatry 45:512-515, 1984

• Herman, J. B., Brotman, A. W. and Rosenbaum, J. F.:Rebound anxiety in panic disorder patients treated with shorter-acting benzodiazepines.J. Clin Phychiatry 48:22-28, 1987

• Hibbert, G.:Ideational components of anxiety:their origin and content. Br. J. Psychiatry 144:618-624, 1984
  pubmed

• Himle, J. and Hill, E.:Alcohol abuse and the anxiey disorders:evidence from the Epidemiologic Catchment Area Survey.J. Anxiety Disord. 5:237-245, 1991

• Himle, J., McPhee, K., Cameron, O. et al.:Simple phobia:evidence for heterogeneity. Psychiatry. Res 28:25-30, 1989
  pubmed

• Hirschfeld, R. M. A.:Panic disorder:diagnosis and course. In:Paper presented at the 17th Congress of Collegium Internationale Neuro-Psychopharmacologicum, Tokyo, Japan, September, 1990

• Hirschfeld, R. M. A.:The clinical course of panic disorder and agoraphobia. In:Handbook of Anxiety Disorders. eds. by Burrows. G., Roth, M. and Noyes, R., Elsevier, Amsterdam, Netherlands, 1992, pp. 105-119

• Hoes. M. J., Colla, P. and Folgerin, H.:Clomipramine treatment of hyperventilation syndrome. Pharmakopsky 13:25-28, 1980

• Hollander, E, Leibowitz, M. R. and Gorman, J. M.:Anxiety disorders. In:American Psy-chiatric Press Textbook of Psychiatry. eds. by Talbott, J. A., Hales, R. E. and Yudofsky, S. C., American Psychiatric Press, Washington, DC, 1988, pp. 443-491

• Hopper, J. L., Judd, F. K., Derrick, P. L. et al.:A family study of panic disorder. Genet. Epimiol. 4:33-41, 1987

• Jannoun, L., Munby, M., Catalan, J. et al.:A home-based treatment programme for agoraphobia:replication and controlled evaluation. Behav. Ther. 11:294-305, 1980

• Jansson, L. and Ost, L. G.:Behavioral treatments for agoraphobia:an evaluative review. Clin. Psychol.Psychol. Rev. 2:311-337, 1982

• Jansson, L., Jerremalm, A. and Ost, L. G.:Follow-up of agoraphobic patients treated with exposure in vivo or applied relaxation. Br. J. Psychiatry 149:486-490, 1986
  pubmed

• Johnson, J., Weissman, M. M. and Klerman, G. L.:Panic disorder, comorbidity, and suicide attempts. Arch. Gen. Psychiatry 47:805-808, 1990
  pubmed

• Joyce, P., Bushnell, J., Oakley, B. M. et al.:The epidemiology of panic symptomatology and agoraphobic avoidance. Compr. Psychiatry 30:303-312, 1989

• Kagan, J. and Snidman, W.:Infant predictors of inhibited and uninhibited profiles. Am. Psychol. Soc. 2:40-44, 1991

• Kagan, J., Reznick, J. S. and Snidman, W.:Biological basis of childhood shyness. Science 240:167-171, 1988

• Kahn, R. S., Asnes, G. M., Wetzler, S. et al.:Neuroendocrine evidence for serotonin receptors hrpersensitivity in panic disorder. Psychophamacology 96:360-364, 1988

• Katon, W. (National Institute of Mental Health):In:Panic disorder in the medical setting (DHHS Publ. No. ADM-89-1629). U. S. Government Printing Office, Washington, DC, 1989, pp. 56-59

• Katon, W. J.:Chest pain, cardiac disease and panic disorder. J. Clin. Psychiatry 51 (suppl. 5):27-30, 1990

• Katon, W. J.:In:Panic Disorder in the Medical Setting. American Psychiatric Press, Washington, DC, 1991

• Katon, W. and Roy-Byrne, P. P.:Panic disorder in the medically ill. J. Clin. Psychiatry 50:299-302, 1989

• Katon, W., Hall, M. L, Russo, J. et al.:Chest pain:relationship of psychiatric illness to coronary arteriographic results. Am. J. Med. 84:1-9, 1988
  pubmed

• Katon, W., Vonkorff, M., Lin, E. et al.:Distressed high utilizers of medical care:DSM-III-R diagnoses and treatment needs. Gen. Hosp. Psychiatry 12:355-362, 1990

• Katon, W. J., Von Korff, M. and Lin, E.:Panic disorder:relationship to high medical utilization. Am. J. Med. 92 (suppl. 1A):7-11, 1992

• Katschnig, H. and Amering, M.:Panic attacks and panic disorder in cross-cultural perspective. In:Clinical Aspects of Panic Disorder. ed. by Ballenger, J. C., Wiley-Liss, New York, 1990, pp. 67-80

• Katschnig, H., Stolk, J., Klerman, G. et al.:Disontinuation experiences and long-term treatment follow-up of participants in a dinical drug trial for panic disorder In:Bilogical Psychiatry International Congress Series 968, Vol. 1. eds. by Racagni, G., Brunello, N. and Fukuda, T., Elsevier, New York, 1991, pp. 657-660

• Keller, M. B., Yonkers, K. A., Warshaw, M. G. et al.:Remission and relapse in subjects with panic disorder and panic with agoraphobia:a prospective short interval naturalistic follow-up. Arch. Gen. Psychiatry (in press)

• Kelly, D., Guirguis, W., Frommer, E. et al.:Treatment of phobic states with antidepressants. Br. J. Psychiatry 136:49-51, 1970

• Kendler, K., Neale, M., Kessler, R. et al.:Generalized anxiety disorder in women:a population-based twin study. Arch Gen. Psychiatry. 49:267-272, 1992a

• Kendler, K., Neale, M., Kessler, R. et al.:The genetic epidemiology of phobias in women:the interrelationship of agoraphobia, social phobia, situational phobia and simple phobia. Arch. Gen. Psychiatry 49:273-281, 1992b

• Kerr, T. A., Schapira, K. and Roth, M.:The relationship between premature death and affective disorders. Br. J. Psychiatry 115:1277-1282, 1969
  pubmed

• Klein, D. F.:Delineation of two drug-responsive anxiety syndromes. Psychopharmacologia 5:397-408, 1964
  pubmed

• Klein, D. F.:Anxiety reconceptualized. In:Anxiety:New Research and Changing Concepts. eds. by Klein, D. F. and Rabkin, J. G., Raven Press. New York, 1981, pp. 235-263

• Klein, D. F. and Fink, M.:Psychiatric reaction patterns to imipramine. Am. J. Psychiatry 119:432-438, 1962
  pubmed

• Klerman, G. L.:Overview:the Cross-National Collaborative Panic Study. Arch. Gen. Psychiatry 45:407-412, 1988
  pubmed

• Klerman, G. L.:Depression and panic anxiety:the effect of depressive comorbidity on response to drug treatment of patients with panic disorder and agoraphobia. J. Psychiatr. Res. 24 (suppl. 2):27-41, 1990

• Klerman, G. L.:Panic disorder:strategies for long-term treatment. J. Clin. Psychiatry 52 (supp. 2):3-5, 1991

• Klerman, G. L, Coleman, J. H., Purpura, R. P. et al.:The design and conduct of the Upjohn Cross-National Collaborative Panic Study. Psychopharmacol. Bull. 45:407-412, 1986

• Klerman, G. L, Weissman, M. M., Ouellette, R. et al.:Panic attacks in the community:social morbidity and health care utilization. JAMA 265:742-746, 1991
  pubmed

• Klerman, G. L, Olfson, M., Leon, A. et al.:Measuring the need for mental health care. Health Aff. (Millwood) 11:23-33, 1992
  pubmed

• Klosko, J. S., Barlow, D. H., Tassinari, R. et al.:A comparison of alprazolam and behavior therapy in treatment of panic disorder. J. Consult. Clin. Psychol. 58:77-84, 1990
  pubmed

• Korn, M. L, Kotler, M., Molcho, A. et al.:Suicide and violence associated with panic attacks. Biol. Psychiatry 31:607-612, 1992
  pubmed

• Krieg, J. C. Bronisch, T., Wittchen, H. U. et al.:Anxiety disorders:a long term prospective and retrospective follow up study of former inpatients suffering from an anxiety neurosis or phobia. Acta. Psychiatr. Scand. 76:36-47, 1987
  pubmed

• Kupfer, D. J.:Lessons to be learned for long-term treatment of affective disorders:potential utility in panic disorder. J. Clin. Psychiatry 52:12-17, 1991
  pubmed

• Kushner, M., Sher, K. and Beitman, B.:The relation between alcohol problems and the anxiety disorders. Am. J. Psychiatry 147:685-695, 1990
  pubmed

• Lader, M. H.:Hazards of benzodiazepine treatment of anxiety. In:Handbook of Anxiety Disorders. eds. by Burrows, G., Roth, M. and Noyes, R., Elsevier, Amsterdam, Netherlands, 1992, pp. 221-232

• Last, C., Barlow, D. and O'Brien, G.:Precipitants of agoraphobia:role of stressful life events. Psychol.Rep 54:567-570, 1984

• Leckman, J., Weissman, M., Merikangas, K. et al.:Panic disorder and major depression:increased risk of depression, alcohlism, panic, and phobic disorders in families of depressed probands with panic disorder. Arch. Gen. Psychiatry 40:1055-1060, 1983

• Lee, C., Kwak, Y., Rhee, H. et al.:The nationwide epidemiological study of mental disorders in Korea. Korean Med. Sci. 2:19-34, 1987

• Lelliott, P., Marks, I., McNamee, G. et al.:Onset of panic disorder with agoraphobia:toward an integrated model. Arch. Gen. Psychiatry 46:1000-1004, 1989
  pubmed

• Leon, A. C, Shear, M. K., Portera, L. et al.:Assessing impairment in patients with panic disorder:the Sheehan Disability Scale. Soc. Psychiatry Psychi-atric Epidemiol. 27:78-82, 1992

• Lipman, R. S., Covi, L. and Shapiro, A. K.:The Hopkins Symptom Checklist (HSCL):factors derived from the HSCL-90. J. Affect. Disord. 1:9-24, 1979
  pubmed

• Lydiard, R. B.:Desipramine in agoraphobia with panic attacks:an open, fixeddose study. J. Clin. Psychopharmacol. 7:258-260, 1987
  pubmed

• Lydiard, R. B. and Ballenger, J. C.:Antidepressant in panic disorder and agoraphobia. J. Affect. Disord. 13:153-168, 1987
  pubmed

• Maier, W. and Buller, R.:One year follow up of panic disorder:outcome and prognostic factors. Eur. Arch Psychiatry Neurol. Sci. 238:105-109, 1988
  pubmed

• Malan, D. H.:In:Frontiers of Brief Psychoterapy. Tavistock, London, England, 1976

• Mann, J.:In:Time-Limited Psychotherapy. Harvard University Press, Cambridge, MA, 1973

• Manu, P., Matthews, D. A. and Lane, T. J.:Panic disorder among patients with chronic fatigue. South. Med. J. 84:451-456, 1991
  pubmed

• Maragraf, J., Barlow, D. H., Clark, D. M. et al.:Psychological treatment of panic:work in progress on outcome, active ingredients, and follow-up. Behav. Res. Ther. 31:1-8, 1993

• Markowitz, J. S., Weissman, M. M., Ouellette, R. et al.:Quality of life in panic disorder. Arch. Gen. Psychiatry 46:984-992, 1989
  pubmed

• Marks, I. M.:The classification of phobic disordes. Br. J. Psychiatry 116:377-386, 1970
  pubmed

• Marks, J. M.:Agoraphobia, panic disorder, and related conditions in the DSM-III-R and ICD-10. J. Psychopharmacol. 1:6-12, 1987

• Marks, I. M. and O'Sullivan, G.:Anti-anxiety drug and psychologial treatment effects in agoraphobia/panic and obsessive-compulsive disorders. In:Psychopharmacology Anxiety ed. by Tyrer, P. Oxford University Press, Oxford, England, 1989

• Marks, I. M., Grey, S., Cohen, D. et al.:Imipramine and brief therapist-aided exposure in agoraphobics having self-exposure homework. Arch. Gen. Psychiatry 40:153-162, 1983

• Marks, I. M., Albuquerque, A. D., Cottraux, J. et al.:The efficacy of alprazolam in panic disorder and agoraphobia:a critique of recent reports (letter). Arch. Gen. Psychiatry 46:668-670, 1989

• Martin, R. L, Cloninger, R., Guze, S. B. et al.:Mortality in a follow-up of 500 psychiatric outpatients. Arch. Gen. Psychiatry 42:47-66, 1985

• Maser, J. D. and Cloninger, C. R. (eds.):In:Comorbidity of Mood and Anxiety Disorders. American Psychiatric Press, Washington, DC, 1990

• Masson, O. A., Warshaw, M. and Keller, M. B.:Quality of life:panic disorder vs. generalized anxiety disorder. Am. J. Psychiatry (in press)

• Mathews, A., Teasdale, J., Munby, M. et al.:A home-based treatment program for agoraphobia. Behav. Ther.8:15-924, 1977

• Mavissakalian, M.:Initial depression and response to imipramine in agoraphobia. J. Nerv. Dis. 175:358-361, 1987
  pubmed

• Mavissakalian, M. and Jones, B.:Comparative efficacy and interaction between drug and behavioral therapies for panic/agoraphobia. In:Handbook of Anxiety, Vol.4:Treatment of Anxiety. eds. by Noyes, R. Jr., Roth, M. and Burrows, G. D., Elsevier, Amsterdam, Netherlands, 1990, pp. 73-86

• Mavissakalian, M. and Michelson, L.:Relative and combines effectiveness of therapist-assisted in vivo exposure and imipramine. J. Clin. Psychiatry. 47:117-122, 1986a

• Mavissakalian, M. and Michelson, L.:Two-year follow-up of exposure and imipramine treatment of agoraphobia. Am. J. Clin. Psychiatry 143:1106-1112, 1986b

• Mavissakalian, M. and Perel. J.:Imipramine in the treatment of agoraphobia:dose response ralationships. Am. J. Clin Psychiatry 142:1032-1036, 1985

• Mavissakalian, M. and Perel. J. M.:Protective effects of imipramine maintenance treatment in panic disorder with agoraphobia. Am. J. Psychiatry 149:1053-1057, 1992
  pubmed

• Mavissakalian, M. Michelson, L. and Dealy, R.:Pharmacological treatment of agoraphobia:imipramine vs imipramine with programmed practice. Br. J. Psychiatry 143:348-355, 1983

• McNair, D. M. and Kahn, R. J.:Imipramine compared with a benzodiazepine for agoraphobia. In:Anxiety:New Pesearch and Changing Concepts. eds. by Klein, D. F. and Rabkin, J., Raven Press, New York, 1981, pp. 69-79

• McNamee, G., O'Sullivan, G., Lelliott, P. et al.:Telephone-guided treatment for housebound agoraphobics with panic disorder:exposure vs. relaxation. Behav. Ther. 20:490-497, 1989

• Mellinger, G. D., Balter, M. B. and Uhlenhuth, E. H.:Prevalence and correlates of the long-term regular use of anxiolytics. JAMA 251:375-379, 1984

• Mellman, T. and Uhde, T.:Sleep panic attacks:new clinical findings and theoretical implications. Am. J. Psychiatry 146:1204-1207, 1989
  pubmed

• Mellman, T. A. and Uhde, T. W.:Patients with frequent sleep panic:clinical findings and response to medication treatment. J. Clin. Psychiatry 51:513-516, 1990
  pubmed

• Merikangas, K., Angst, J. and Isler, H.:Migraine and psychopathology. results of the Zurich cohort study of young adults. Arch. Gen. . Psychiatry 47:849-853, 1990
  pubmed

• Michelson, I. K. and Marchione, K.:Behavioral, cognitive, and pharmacological treatments of panic disorder with agoraphobia:critique and synthesis. J. Consult. Clin. Psychol. 59:100-114, 1991

• Michelson, L. K., Marchione, K. and Greenwald, M.:Cognitive-behavioral treatments of panic disorder with agoraphobia:acomparative outcome investigation. In:Emerging Issues Assessment and Treatment of Anxiety Disorders. Chaired by Michelson, L, symposium presented at the meeting of the Association for Advancement of Behavior Therapy, Washington, DC, November, 1989

• Michelson, L, Marchione, K., Greenwald, M. et al.:Panic disorder:cognitive-bevavioural treatment. Behav. Tes. Ther. 28:141-153, 1990

• Miles, H. H. W., Barrabee, E. L and Finesinger, J. E.:Evaluation of psychotherapy with a follow-up study of 62 cases of anxiety neurosis. Psychosom. Med. 13:83-105, 1951
  pubmed

• Milrod, B. and Shear, M. D.:Dynamic treatment of panic disorder:a review. J. Nerv. Ment. Dis. 179:741-743, 1991

• Milton, F. and Hafner, J.:The outcome of behavior the rapy for agoraphobia in relation to marital adjustment. Arch. Gen. Psychiatry 36:807-811, 1979

• Monteiro, W., Marks, I. M. and Ramm, E.:Marital adjustment and treatment outcome in agoraphobia. Br. J. Psychiatry 146:383-390, 1985
  pubmed

• Moran, C. and Andrews, G.:The familial occurrence of agoraphobia. Br. J. Psychiatry 146:262-267, 1985
  pubmed

• Moreau, D. and Weissman, M. M.:Panic disorder in children and adolescents:a review. Am. J. Psychiatry 149:1306-1314, 1992
  pubmed

• Moreau, D. L, Weissman, M. M. and Warner, V.:Panic disorder in children at high risk for depression. Am. J. Psychiatry 146:1059-1060, 1989

• Munby, M. and Johnson, D. W.:Agoraphobia:the long-term follow-up of behavioral treatment. Br. J. Psychiatry 137:418-427, 1980

• Murphy, J.:Trends in depression and anxiety:men and women. Acta Psychiatr. Scand. 73:113-127, 1986
  pubmed

• Nagy, L. M., Krystal, J. H., Woods, S. W. et al.:Clinical and medication outcome after short-term alprazolam and behavioral group treatment in panic disorder. Arch. Gen. Psychiatry 46:993-999, 1989
  pubmed

• Newman, C. F., Beck, J. S., Beck, A. T. et al.:Efficacy of therapy in reducing panic attacks and medication. In:Paper presented at the meeting of the Association for Advancement of Behavior Therapy, San Francisco, CA, November, 1990

• Nordahl, T. E, Semple, W. E., Gross, M. et al.:Cerebral glucose metabolic differences in patients with panic disorder. Nueropsychopharmacology 3:261-272, 1990
  pubmed

• Norman, T. R., Judd, F. K., Marriott, P. F. et al.:Physical of anxiety:the benzodiazepines. In:Handbook of Anxiety, Vol.1:Biological, Clinical and Cultural Perspectives. eds. by Roth, M., Noyes, R. Jr. and Burrows, G. D., Elsevier, Amsterdam, Netherlands, 1988, pp. 355-383

• Norton, G., Cox, B. and Schwartz, M.:Critical analysis of the DSM-III-R classification of panic disorder:a survey of current opinions. J. Anxiety Disord. 6:159-167, 1992

• Noyes, R., Reich, J., Clancy, J. et al.:Reduction in hypochondriasis with treatment of panic disorder. Br. J. Psychiatry 149:631-635, 1986a

• Noyes, R. Jr., Crowe, R. R, Harris, E. L. et al.:Relationship of panic disorder and agoraphobia:a family study. Arch. Gen. Psychiatry 43:227-232, 1986b

• Noyes, R. Jr., Garvey, M. J. and Cook, B. L.:Follow-up study of pateints with panic disorder and agoraphobia with panic attacks trearted with tricyclic antidepressants. J. Affect. Disord. 16:249-257, 1989a

• Noyes, R. Jr., Garvey, M. J. and Cook, B. L.:Problems with tricyclic antidepressant use in patients with panic disorder or agoraphobia:results of a naturalistic follow-up study. J. Clin. Psychiatry 50:163-169, 1989b
  pubmed

• Noyes, R. Jr., Reich, J., Christiansen, J. et al.:Outcome of panic disorder:relationship to diagnostic subtypes and comorbidity. Arch. Gen. Psychiatry 47:809-818, 1990
  pubmed

• Noyes, R. Jr., Garvey, M. J., Cook, B. et al.:Controlled discontinuation of benzodiazepine treatment for patients with panic disorder. Am. J. Psychiatry 148:517-523, 1991
  pubmed

• Noyes, R. Jr., Garvey, M. J. and Cook, B.:Controlled discontinuation of benzodiazepine treatment for patients with panic disorder (comment). Am. J. Psychiatry 148:1621, 1992

• Nunes, E., Quitkin, F. and Berman, C.:Panic disorder and depresstion in female alcoholics. J. Clin. Psychiatry 49:441-443, 1988
  pubmed

• Nutt, D. J.:The neurochemistry of anxiety:an update program. Prog. Neuropsychopharmacol Biol. Psychiatry. 14:737-752, 1990

• Nutt, D. J. and Cowen, P. J.:Diazepam alters brain 5HT function in man:implications for the acute and chronic effects of benzodiazepines. Psychol. Med. 17:601-607, 1987
  pubmed

• Ost, L. G.:Applied relaxation:description of a coping technique and review of controlled studies. Behav. Res. Ther. 26:13-22, 1987

• Ost, L. G.:Applied relaxation in the treatment of panic disorder. Behav. Res. Ther. 26:13-22, 1988
  pubmed

• Ost, L. G., Hellstrom, K. and Westling, B.:Exposure, applied relaxation, and cognitive techniques in the treatment of agoraphobia. Behav. Res. Ther. (in press)

• Ottaviani, R. and Beck, A. T.:Cognitive aspects of panic disorders. J, Anxiety Disord. 1:15-28, 1987

• Parker, G.:Reported parental characteristics of agoraphobics and social phobics. Br. J. Psychiatry 135:555-560, 1979
  pubmed

• Parker, G., Tupling, H. and Brown, L. B.:A parental bonding instrument. Br. J. Med. Psychol. 52:1-10, 1979

• Pauls, D. L., Bucher, K. D., Crowe, R. R. et al.:A genetic study of panic disorder pedigrees. Am. J. Hum. Genet. 35:639-644, 1980

• Pecknold, J. C.:Discontinuation studies:short-term and long-term. In:Paper presented at Symposium on Panic Awareness for Clinicians, chaired by Ballenger, J. C. and La Costa, C. A., November, 1990

• Pecknold, J. D., Swinson, R. P., Kuch, K. et al.:Alprazolam in panic disorder and agoraphobia;results from a multicenter trial, III:discontinuation effects. Arch. Gen. Psychiatry 45:429-436, 1988

• Pecknold, J. C., McClure, D. J., Appletauer, L. et al.:Does tryptophan potentiate clomipramine in the treatment of agoraphobic and social phobic patients? Br. J. Psychiatry 140:484ff, 1990

• Perris, C., Jacobsson, L., Lindstrom, H. et al.:Development of a new inventory for assessing memories of parental rearing behavior. Acta Psychiatr. Scand. 61:265-274, 1980
  pubmed

• Perugi, G., Deltito, J., Soriani, A. et al.:Relationships between panic disorder and separation anxiety with school phobia. Compr. Psychiatry 29:98-107, 1988
  pubmed

• Pitts, F. N. and McClure, J. N.:Lactate metabolism in anxiety neurosis. N. Engl. J. Med. 277:1329-1336, 1967
  pubmed

• Pohl, R, Yeregani, V. K., Balon, R. et al.:The jitteriness syndrome in panic disorder patients treated with antidepressants. J. Clin. Psychiatry 49:100-104, 1988

• Priest, R. G.:The homeless person and the psychiatric services:an Edinburgh servey. Br. J. Psychiatry 128:128-136, 1976

• Priest, R. G. and Laffront, I:British and French classification of mental disorders. Ann. Med. Psychol. 150:313-317, 1992

• Rashkin, A.:Role of depression in the antipanic effects of antidepressant drugs. In:Clinical Aspects of Panic Disorder. ed.by Ballenger, J. C., Alan R Liss, New York, 1990, pp. 169-180

• Regier, D. A., Myers, J. K., Kramer, M. et al.:The NIMH Epidemiologic Catchment Area Program:historical context, major obstacles, and study population characteristics. Arch. Gen. Psychiatry 41:934-941, 1984

• Reich, J., Noyes, R. and Troughton, E.:Dependent personality disorder associated with phobic avoidance in patients with panic disorder. Am. J. Psychiatry 144:323-326, 1987
  pubmed

• Rickels, K., Case, G., Downing, R. G. et al.:Long-term diazepam therapy and clinical outcome. JAMA 250:767-771, 1983

• Rickels, K., Schweizer, E., Osanalosi, et al.:Long-term treatment of anxiety and risk of withdrawal. Arch Gen. Psychiatry 45:444-450, 1988
  pubmed

• Rickels, K., London, J., Fox, I. et al.:Adinazolam, diazepam, imipramine and placebo in major depressive disorder:a controlled study. Pharmacopsychiatry 24:127-131, 1991
  pubmed

• Robins, E. and Guze, S.:Establishment of diagnostic validity in psychiatric illness:its application to schizophrenia. Am. J. Psychiatry 126:107-111, 1970

• Robins, L. N. and Regier, D. A. (eds):In:Psychiatric Disorders in America:The ECA Study. Free Press, New York, 1991

• Robins, L. N, Helzer, J. E. and Croughan. J. L.:In:Renard Diagnostic Interview. St. Louis. MO, Washington University School of Medicine, 1977

• Robins, L. N., Helzer, J. E, Croughan. J. et al.:National Institute of Mental Health Diagnostic Interview Schedule:its history, characteristics, and validity. Arch. Gen. Psychiatry 38:381-389, 1981
  pubmed

• Rogers, M. P., White, K., Warshaw, M. G. et al.:The ralationship between anxiety disorders and medical illnesses. Psychosom. Med. 53:219-220, 1991

• Rosenbaum, J. F.:New uses for clonazepam in psychiatry. J. Clin. Psychiatry 48 (suppl. 3), 1987

• Rosenbaum, J., Biederman, J., Bolduc, E. A. et al.:Comorbidity of parental anxiety disorder as risk for childhood-onset anxiety in inhibited children. Am. J. Psychiatry 149:475-481, 1992
  pubmed

• Roth, M.:The phobic anxiety-depersonalization syndrome and some general aetiological problems in psychiatry J. Neuropsychiatry 1:293-306, 1960

• Roth, M. and Argyle, N.:Anxiety, panic and phobic disorders:an overview. Key Biscayne Conference on Anxiety Disorders, Panic Attacks and Phobias (1982, Key Biscayne, Florida). J. Psychiatr. Res. 22:(suppl. 1):33-54, 1988

• Roy-Byrne, P. and Lydiard, B.:New developments in the psychopharmacologic treatment of anxiety. In:Anxiety:New Findings for the Clinician. ed. by Roy-Byrne, P., American Psychiatric Association, Washington, DC, 1989, pp. 149-178

• Roy-Byrne, P., Geraci, M. and Uhde, T.:Life events and the onset of panic disorder. Am. J. Psychiatry 143:1424-1427, 1986
  pubmed

• Roy-Byrne, P., Ashley, E. A. and Carr, J.:Personality and the anxiety disorders:a review of clinical findings. In:Handbook of the anxiety Vol. 2:The Phenomenology of Anxiety. eds. by Noyes, R., Roth, M. and Burrows, G. D., Elsevier, Amsterdam, Netherlands, 1988

• Roy-Byrne, P. P., Cowley, D. S., Greenblatt, D. J. et al.:Reduced benzodiazepine sensitivity in panic disorder. Arch. Gen. Psychiatry 47:534-538, 1990
  pubmed

• Salkovskis, P. M., Jones, D. R. O. and Clark, D. M.:Respiratory control in the treatment of panic attacks:replication and extension with concurrent measurement of behaviour and pCO2. Br. J. Psychiatry 148:526-532, 1986

• Salkovskis, P. M., Clark, D. M. and Hackmann, A.:Treatment of panic attacks using cognitive restructuring without exposure or breathing retraining. Behav. Res. Ther. 29:161-166, 1991
  pubmed

• Sargant, W. and Dally, P.:Treatment of anxiety states by antidepressant drugs. Br. Med. J. 1:6-9, 1962
  pubmed

• Schatzberg, A. F. and Ballenger, J. C.:Decisions for the clinician in the treatment of panic disorder:when to treat, which treatment to use, and how long to treat. J. Clin. Psychiatry 54 (suppl):26-31, 1991

• Schneier, F. R, Leibowitz, M. R, Davies, S. O. et al.:Fluoxetine in panic disorder. J. Clin. Psychopharmacol. 10:119-121, 1990

• Schneier, F, Johnson, J., Hornig, C. et al.:Social phobia:comorbidity and morbidity in an epidemiologic sample. Arch. Gen. Psychiatry 49:282-288, 1992

• Schweitzer, E., Rickels, K., Weiss, S. et al.:Maintenance drug treatment of panic disorder, I:results of a prospecive, placebo-controlled comparison of alprazolam and imipramine. Arch. Gen. Psychiatry 50:51-60, 1993

• Sciuto, G., Diaferia, G., Battaglia, M. et al.:DSM-III-R personality disorders in panic and obsessive compulsive disorder:a comparison study. Compr. Psychiatry 32:450-457, 1991
  pubmed

• Sethy, V. H. and Hodges, D. H.:Alprazolam in biochemical model of depression. Biochem. Pharmacol. 31:3155-3157, 1982
  pubmed

• Shear, M. K., Ball, G., Fitzpatrick, M. et al.:Cognitive-behavioral therapy for panic:an open study. J. Nerv. Ment. Dis. 179:467-471, 1991

• Sheehan, D. V.:Current views on the treatment of panic and phobic disorders. Drug Ther. Hosp. 7:74-93, 1982

• Sheehan, D. V.:In:The Anxiety Disease. Scribners, New York, 1983

• Sheehan, D. V.:One-year follow-up of patients with panic disorder, and withdrawal from long-term antipanic medication. In:Program and Abstract of the Panic Disorder Biological Research Workshop, Washington, DC, Apri, 1986

• Sheehan, D. V., Ballenger, J. C., Jacobson, G. et al.:Treatment of endogenous anxiety with phobic, hysterical, and hypochondriacal symptoms. Arch. Gen. Psychiatry 36:51-59, 1980

• Sheehan, D. V., Raj, B. A., Sheehan, K, H. et al.:Is buspirone effective for panic disorder? J. Clin. Psychopharmacol. 10:2-11, 1990

• Sifneos, P. E.:Short-Term Dynamic Psychotherapy:In:Evaluation and Technique. Plenum, New York, 1979

• Silove, D.:Perceived parental characteristics and reports of early parental deprivation in agoraphobic patients. Aust. N. Z. J. Psychiatiy 20:365-369, 1986

• Sokol, L, Beck, A. T., Greenberg, R. I. et al.:Cognitive therapy of panic disorder:a non-pharmacologic alternative. J. Nerv. Ment. Dis. 177:711-716, 1989

• Solyom, L., Beck, P., Solym, C. et al.:Some etiological factors in phobic neurosis. Can. Psychiatr. Assoc. J. 19:69-78, 1991

• Spier, S. A., Tesar, G, E., Rosenbaum, J. F. et al.:Treatment of panic disorder and agoraphobia with clonazepam. J. Clin. Psychiatry 47:238-242, 1986
  pubmed

• Spitzer, R. L, Endicott, J. and Robins, E.:Research diagnostic criteria:rationale and reliability. Arch. Gen. Psychiatry 35:773-779, 1978
  pubmed

• Starcevic, V.:Relationship between panic disorders, agoraphobia, and personality disturbance:an overview of research findings, and pertinent issues. Psihijatrija Danas. 23:57-70, 1991

• Stavrakaki, C. and Vargo, B.:The relationship of anxiety and depression:a review of the literature. Br. J. Psychiatry 149:7-16, 1986
  pubmed

• Stewart, W. F., Linet, M. S. and Celentano, D. D.:Migraine headaches and panic attacks. Psychosom. Med. 51:559-569, 1989
  pubmed

• Tainey, J., Pohl, R., Williams, M. et al.:A comparison of lactate and isoproterenol anxiey states. Psychopathology 17:74-82, 1984

• Taylor, C. B., Hayward, C., King, R. et al.:Cardiovascular and symptomatic reduction effects of alprazolam and imipramine in patients with panic disorder:results of a double-blind, placebo-controlled trial. J.Clin. Psychopharmacol. 10:112-118, 1990

• Telch, M., Agras, W., Taylor, C. et al. .:Combined pharmacological and behavioral treatment for agoraphobia. Behav. Res. Ther. 23:335-355, 1985a

• Telch, M., Agras, W., Taylor, C. et al.:Imipramine and behavioral treatment for agoraphobia. Behav. Res. Ther. 23:325-335, 1985b

• Tesar, G. E. and Rosenbaum, J. F.:Successful use of clonazepam in patients with treatment-resistant panic disoeder. J. Nerv. Ment. Dis. 174:477-482, 1986
  pubmed

• Torgersen, S.:Genetic factor in anxiety disorders. Arch. Gen. Psychiatry 40:1085-1089, 1983
  pubmed

• Torgersen, S.:Childhood and family characteristics in panic and generalized anxiety disorders. Am. J. Psychiatry 143:630-632, 1986
  pubmed

• Tucker, W. I.:Diagosis and treatment of the phobic reaction. Am. J. Psychiatry 112:825-830, 1956

• Tyrer, P. J., Candy, J. and Kelly, D. A.:A study of the clinical effects of phenelzine and placebo in the treatment of phobic anxiety. Psychopharmacologia 32:237-254, 1973

• Tyrer, P., Rutherford, D. and Huggett, T.:Benzodiazepine withdawal symptoms and propranolol. Lancet 88:520-522, 1981

• Tyrer, P. J., Owen, R. and Dawling, S.:Gradual withdrawal of diazepam after long-term therapy. Lancet 1:1402-1406, 1983

• Uhde, T. W., Boulenger, J. P., Vittone, B. et al.:Human anxiety and nonadrenergic function:preliminary studies with caffeine, clonidine and yohimbine. In:Proceedings of the Seventh World Congress of Psychiatry. Plenum, New York, 1985

• Uhlenhuth, E. H. and Balter, M. B.:Clinical variables in pharmacoepidemiology. J. Psychiatr. Res. (in press)

• Uhlenhuth, E. H., Balter, M. B., Mellinger, G. D. et al.:Symptom checklist syndromes in the general population:correlations with psychotherapeutic drug use. Arch. Gen. Psychiatry 40:1167-1173, 1983
  pubmed

• Uhlenhuth. E. H., Balter, M. B. and Mellinger, G. D.:Anxiety disorders:prevalence and treatment. Curr. Med. Res. Opin. 8 (suppl. 4):37-47, 1984

• Uhlenhuth. E. H., Matsuzas, W., Glass, R. M. et al.:Response of panic disorder to fixed dose of alprazolam or imipramine. J. Affect, disord. 17:261-270, 1989
  pubmed

• Uhlenhuth. E. H., Balter, M. B. and Mellinger, G. D.:Clinical variables in pharmaco-epidemiology. J. Psychiatr. Res. 24 (suppl.):15-16, 1992

• van den Hout, M. A. and Griez, E.:Cardiovascular and subjective responses to inhalation of carbon dioxide. Psychother. Psychosom. 37:75-82, 1982
  pubmed

• Vangaard, T.:Panic:In:The Course Psychoanalysis, 1st Edition. Translated by Vangaard, J., WW Norton, New York, 1989

• Versiani, M., Gentile, V., Paprocki, J. et al.;Data about 508 cases of panic disorder and responses to treatment with alprazolam clomipramine, imipramine, and tranylcypromine:In:Bio. Psychiatry:Proceedings from the IVth World Congress of Biological Psychiatry. eds. by Shagass, C., Josiassen, R. D., Bridger, W. H. et al. Elsevier, Amsterdam, Netherlands, 1985

• Villacres, E. C., Hollifield, M., Katon, W. I. et al.:Sympathetic nervous system activity in panic disorder. Psychiatry Res. 21:313-321, 1987
  pubmed

• Vyas, I. and Carney, M. W. P.:Diazepam withdrawal fits. Br. Med. J. 4:44, 1975

• Walker, E. A., Roy-Byrne, P. P., Katon, W. J. et al.:Psychiatric illness and irritable bowel syndrome:a comparison with inflammatory bowel disease. Am. J. Psychiatry 147:1656-1661, 1990
  pubmed

• Waxman, D.:A clinical trial of clomipramine and diazepam in the treatment of phobic and obsessional illness. J. Int. Med. Res. 5:99-110, 1977

• Weissman M. M.:The epidemiology of panic disorder and agoraphobia. In:American Psychiatric Association Annual Review of Psychiatry, Vol. 7:eds. by Hales, R. E. and Frances, A. J., American Psychiatric Press, Washington, DC, 1988, pp. 54-66

• Weissman, M. M.:Family genetic studies of panic disorder. In:Paper presented at the Conference on Panic and Anxiety:A Decade of Progress, Geneva, Switzerland, June, 1990

• Weissman, M. M.:Panic disorder:impact on quality of life. J. Clin. Psychiatry 52:6-9, 1991
  pubmed

• Weissman, M. M.:Family genetic studies of panic disorder. J. Psychiatr. Res. (in press)

• Weissman, M. M., Klerman, G. L., Markowitz, J. S. et al.:Suicidal ideation and suicide attempts in panic disorder and attacks. N. Engl. J. Med. 321:1209-1214, 1989
  pubmed

• Weissman, M. M., Markowitz, J. S., Ouellette, R. et al.:Panic disorder and cardiovascular/cerebrovascular problems:results from a community survey. Am. J. Psychiatry 147:1504-1508, 1990
  pubmed

• Wells. K., Burnam. M., Leake, B. et al.:Agreement between face and telephone administered versions of the depression section of the NIMH Diagnostic Interview Schedule. J. Psychiat. Res. 22:207-220, 1988
  pubmed

• Wells, K. B., Stewart, A. L., Hays, R. D. et al.:The functioning and well-being of depressed patients:results from the Medical Outcome Study. JAMA 262:914-919, 1989

• West, E. D. and Dally, P. L.:Effect of iproniazid in depressive syndromes. BMJ 1:1491-1494, 1959

• Westphal, C.:Die Agoraphobie, eine neuropathische Erscheinung. Arch. Psychiatr. Nervenkr. 3:138-161, 1872

• Wheeler, E. D., White, P. D., Reed, E. W. et al.:Neurocirculatory asthenia:a 20-year follow-up study of 173 patients. JAMA 142:878-889, 1950

• Wing, J. K., Cooper, J. E. and Sartorius, N.:Measurement and Classification of Psychiatric Symptoms:In:An Instructional Manual the PSE and CATEGO Program. Cambridge University Press, New York, 1974

• Wittchen, H. U, Ahmoi, E. C., Von, Z. D. et al.:Lifetime and six month prevalence of mental disorders in the Munich Follow Up Study. Eur. Arch Psychiatry. Clin. Neurosci. 241:247-258, 1992

• World Health Organization:In:International Classification of diseases, 9th Edition. World Health Organization, Geneva, Switzerland, 1978

• World Health Organization:In:Draft of the International Classification of Diseases and Related Health Problems, 10th Edition. World Health Organization, Geneva, Switzerland, 1990

• World Health Organization:In:International Classification of Diseases and Related Health Problems, 10th Edition. World Health Organization, Geneva, Switzerland, 1992

• Wulsin, L. R., Hillard, J. R, Grier, P. et al.:Screening emergency room patients with atypical chest pain for depression and panic disorder. Int. J. Psychhiatry Med. 18:315-323, 1988

• Zandbergen, J., Pols, H., Fernandez, I. et al.:An analysis of panic symptoms during hypercarbia compared to hypocarbia in patients with anxiety. J. Affect. Disord. 23:131-136, 1991
  pubmed

• Zilber, N., Schufman, A. and Lerner, Y.:Mortality among psychiatric putpatients:the group at risk. Acta Psychiatr. Scand. 79:248-256, 1989

• Zitrin, C. M., Klein, D. F. and Woerner, M. G.:Treatment of agoraphobia with group exposure in vivo and imipramine. Arch. Gen. Psychiatry 37:63-72, 1980
  pubmed

• Zitrin, C. M., Klein, D. F., Woerner, M. G. et al.:Treatment of phobias, I:Comparison of imipramine hydrochloride and placebo. Arch. Gen. Psychiatry 40:125-138, 1983
  pubmed

P.169 掲載の参考文献

• Allgulander, C. and Fisher, L. D.:Clinical predictors of completed suicide and repeated self-poisoning in 8895 self-poisoning Patients. Eur. Arch. Psychiatry Neurol. Sci. 239:270-276, 1990
  pubmed

• Allsopp, L. F., Cooper, G. L. and Poole, P. H.:Clomipramine and diazepam in the treatment of agoraphobia and social phobia in general practice. Curr. Med. Res. Opin. 9:64-70, 1984
  pubmed

• American Psychiatric Association:In:Task Force on Benzodiazpine Dependence, Toxicity and Abuse. American Psychiatric Association, Washington, DC, 1990

• Amering, M. and Katschnig, H.:Long-term fate of specific agoraphobic fears in panic disorder. In:Paper presented at the annual meeting of the American Psychiatric Association, New Orleans, LA, May, 1991

• Angst, J. and Dobler, M.:The Zurich study. Eur. Arch. Psychiatry Neurol. Sci. 235:171-178, 1985

• Ballenger, J. C.:Drug treatment of panic disorder and agoraphobia. In:CME Syllabus and Proceedings Summary of the 140th Annual Meeting American Psychiatric Association, Chicago, IL, 1987

• Ballenger, J. C.:The clinical use of carbamazepine in affective disorders. J. Clin. Psychiatry 49:13-21, 1988
  pubmed

• Ballenger, J. C. (ed):In:Clinical Aspects of Panic Disorder. Alan R Liss, New York, 1990a

• Ballenger, J. C.:Efficacy of benzodiazepines in panic disorder and agoraphobia. J. Psychiatr. Res. 24:15-25, 1990b

• Ballenger, J. C. (ed):In:Neurobiology of Anxiety. Alan R Liss, New York, 1990c

• Barbaccia, M., Costa, E, Ferrero, P. et al.:Diazepam binding inhibitor. a brain neuropeptide present in human spinal fluid. studies in depression, schizophrenia and Alzheimer's disease. Arch. Gen. Psychiatry 43:1143-1147, 1986
  pubmed

• Barlow, D. H.:Long-term outcome for patients with panic disorder treated with cognitive-behavioral therapy. J. Clin. Psychiatry 51:17-23, 1990
  pubmed

• Beard, G, M.:A Practical Treatise on Nervous Exhaustion (Neurasthenia). Its Symptoms, Nature, Sequence, Treatment. Wood, New York, 1880

• Beaudry, P., Fontaine, R. and Chouinard, G.:Bromazepam, another high-potency benzodiazepine, for panic attacks. Am. J. Psychiatry 141:464-465, 1984
  pubmed

• Bech, P.:Quality of life measurement in the medical setting. Int. J. Meth. Psychiatr. Res. 2:139-144, 1992

• Beck, A. T.:Cognitive approaches to panic disorder:theory and therapy. In:Panic:Psychological Perspectives. eds. by Rachman, S. and Maser, J., Erlbaum, Hillsdale, NJ, 1988

• Brown, J. L. and Hauge, K. J.:A review of alprazolam withdrawal. Drag Intell. Clin. Pharm. 20:837-841, 1986

• Brown, S., Irwin, M. and Schuckit, M.:Changes in anxiety among abstinent male alcoholics. J. Stud. J. Alcohol 52:55-61, 1991
  pubmed

• Buigues, J. and Vallejo, J.:Therapeutic response to phenelzine in patients with panic disorder and agoraphobia with panic attacks. J. Clin. Psychiatry 48:55-59, 1987
  pubmed

• Buller, R. and Amering, M.:Follow-up in subtypes of panic disorder. In:Paper presented at the 5th World Congress of Biological Psychiatry. Florence, Italy, June, 1991

• Buller, R., Maier, W. and Benkert, O.:Clinical subtypes in panic disorder. their descriptive and prospective validity. J. Affect. Disord. 11:105-114, 1986
  pubmed

• Busto, U. and Sellers, E. M.:Pharmacokinetic determinants of drug abuse and dependence. a conceptual perspective. Clin. Pharmacokinet. 11:144-153, 1986
  pubmed

• Busto, U., Sellers, E. M., Naranjo, C. A. et al.:Withdrawal reaction after longterm therapeutic use of benzodiazepines. N. Engl. J. Med. 315:854-859, 1986
  pubmed

• Cameron, O., Thyer, B., Nesse, R. et al.:Symptom profiles of patients with DSM III anxiety disorders. Am. J. Psychiatry 143:1132-1137, 1986
  pubmed

• Canino, G. J., Bird, H. R., Shrout, P. E. et al.:The prevalence of specific psychiatric disorders in Puerto Rico. Arch. Gen. Psychiatry 44:727-735, 1987
  pubmed

• Cassano, G. B., Petracca, A., Perugi, G. et al.:Clomipramine for panic disorder. the first 10 weeks of a long-term comparison with imipramine. J. Affect. Disord. 14:123-127, 1988
  pubmed

• Cassem, E. H.:Depression and anxiety secondary to medical illness. Psychiatr. Clin. North Am. 13:597-612, 1990
  pubmed

• Cerny, J. A., Barlow, D. H., Craske, M. G. et al.:Couples treatment of agoraphobia. a two-year follow-up. Behav. Res. Ther. 18:401-415, 1987

• Charney, D. S. and Heninger, G. R.:Abnormal regulation of noradrenergic function in panic disorder. Am. J. Psychiatry 43:177-189, 1986

• Charney, D. S. and Woods, S. W.:Benzodiazepine treatment of panic disorder. a comparison of alprazolam and lorazepam. J. Clin. Psychiatry 50:418-423, 1989
  pubmed

• Charney, D. S., Heninger, G. R. and Breier, A.:Noradrenergic function and panic anxiety effects of yohimbine in health subjects and patients with agoraphobia and panic disorder. Arch. Gen. psychiatry 41:751-763, 1984

• Charney, D., Heninger, G. and Jatlow, P.:Increased anxiogenic effects of caffeine in panic disorders. Arch. Gen. Psychiatry 42:233-243, 1985
  pubmed

• Charney, D. S., Woods, S. W., Goodman, W. K. et al.:Drug treatment of panic disorder. the comparative efficacy of imipramine, alprazolam, and trazodone. J. Clin. Psychiatry 47:580-586, 1986
  pubmed

• Chrney, D. S., Woods, S. W., Goodman, W. K. et al.:Neurobiological mechanisms of panic anxiety. biochemical and behavioral correlates of yohimbine-induced panic attacks. Am. J. Psychiatry 144:1030-1036, 1987

• Charney, D. S., Woods, S. W., Nagy, L. M. et al.:Noradrenergic function of panic disorder. J. Clin. Psychiatry 51 (suppl. 12A):5-11, 1990

• Chouinard, G., Annable, L., Fontaine, R. et al.:Alprazolam in the treatment of generalized anxiety and panic disorders. a double-blind placebo-controlled study. Psychopharmacology (Berl.) 77:229-233, 1982
  pubmed

• Clark, D. M.:A cognitive approach to panic. Behav. Res. Ther. 24:461-470, 1986
  pubmed

• Clark, D. M., Salkovskis, P. M. and Chalkley, A. J.:Respiratory control as a treatment for panic attacks. J. Behav. Ther. Exp. Psychiatry 16:23-30, 1985
  pubmed

• Clark, D. M., Salkovskis, P. M., Gelder, M. G. et al.:Tests of cognitive theory of panic. In:Panic and Phobias II. eds. by Hand, I. and Wittchen, H. U. Springer-Verlag, New York, 1988

• Clark, D. M., Salkovskis, P. M., Hackmann, A. et al.:A comparison of cognitive therapy, applied relaxation and imipramine in the treatment of panic disorder (submitted for publication).

• Cohen, M. E, Badal, D. W., Kilpatrick, A. et al.:The high familial prevalence of neurocirculatory asthenia (anxiety neurosis, effort syndrome). Am. J. Hum. Genet. 3:126, 1951
  pubmed

• Committee on the Review of Medicines:Systematic review of the benzodiazepines. Br. Med. J. 1:910-912, 1980

• Coryell, W.:Mortality of anxiety disorders. In:Handbook of Anxiety Vol. 2. Classification, Biological Factors and Associated Disturbances. eds. by Noyes, R. Jr., Roth, M. and Burrows, G. D., Elsevier, Amsterdam, Netherlands, 1988, pp. 311-320

• Coryell, W., Noyes, R. and Clancy, J.:Excess mortality in panic disorder. a comparison with primary unipolar depression. Arch. Gen. Psychiatry 39:701-703, 1982
  pubmed

• Coryell, W., Noyes, R. and House, J. D.:Mortality among outpatients with panic disorder. Am. J. Psychiatry 143:508-510, 1986
  pubmed

• Cowley, D. S. and Roy-Byrne, P.:Psychosocial aspects. Psychiatr. Ann. 18:464-467, 1988

• Craske, M. and Barlow, D.:A review of the relationship between panic and avoidance. Clin. Psychol. Rev. 8:667-685, 1988

• Cross-National Collaborative Panic Study:Drug treatment of panic disorder. comparative efficacy of alprazolam, imipramine, and placebo. Br. J. Psychiatry 160:191-202, 1992
  pubmed

• Crowe, R. R.:Family and twin studies of panic disorder and agoraphobia. In:Handbook of Anxiety, Vol.1 Biological, Clinical and Cultural Perspectives. eds. by Roth, M., Noyes, R. Jr. and Burrows, G. D., Elsevier, Amsterdam, Netherlands, 1988, pp. 101-114

• Davidson, J. R. T.:Continuation treatment of panic disorder with high-potency benzodiazepines. J. Clin. Psychiatry 51:31-37, 1990

• de la Fuente, J. R.:Drug treatment of panic anxiety. In:Paper presented at the 141st annual meeting the American Psychiatric Association, Montreal, Quebec, Canada, May, 1988

• Dunner, D. L., Ishiki, D., Avery, D. H. et al.:Effect of alprazolam and diazepam on anxiety and panic attacks in panic disorder. a controlled study. J. Clin. Psychiatry 47:458-460, 1986
  pubmed

• Dupont, R. L.:Thinking about stopping treatment for panic disorder. J. Clin. Psychiatry 51:38-45, 1990
  pubmed

• Eaton, W. W. and Kessler, L. G.:Epidemiologic field methods in psychiatry. In:the NIMH Epidemiologic Catchment Area Program. Academic Press, Orlando, FL, 1985

• Eaton, W. W., Holzer, C. E. III., Von Korff, M. et al.:The design of the Epidemiologic Catchment Area surveys. the control and measurement of error. Arch. Gen. Psychiatry 41:942-948, 1984

• Eaton, W. W., Dryman, A. and Weissman, M. M.:Panic and phobia. In:Psychiatric Disorderds in America. eds. by Robins, L. N. and Regier, D. A., Free Press, New York, 1990, pp. 155-179

• Edwards, J. G., Inman, W. H. W., Pearce, G. L. et al.:Prescription-event monitoring of 10895 patients treated with alprazolam. Br. J. Psychiatry 158:387-392, 1991

• Escobar, J. I. and Landbloom, R. P.:Treatment of phobic neurosis with clomipramine. a controlled clinical trial. Curr. Ther. Res. 20:680-685, 1976
  pubmed

• Faravelli, C. and Pallanti, S.:Recent life events and panic disorder. Am. J. Psychiatry 146:622-626, 1989
  pubmed

• Faravelli, C., Webb, T., Ambonetti, A. et al.:Prevalence of traumatic early life events in 31 agoraphobic patients with panic attacks. Am. J. Psychiatry 142:1493-1494, 1985
  pubmed

• Fawcett, J.:Targeting treatment in patients with mixed symptoms of anxiety and depression. J. Clin. Psychiatry 51:40-43, 1990
  pubmed

• Fontaine, R., Chouinard, G. and Annable, K.:Rebound anxiety in anxious patients after abrupt withdrawal of benzodiazepine treatment. Am. J. Psychiatry 141:848-852, 1984

• Fossey, M. D. and Lydiard, R. B.:Anxiety and the gastrointestinal system. Psychiatr. Med. 8:175-186, 1990
  pubmed

• Fyer, A. J. and Sandberg, D.:Pharmacologic treatment of panic disorder. In:Review of Psychiatry, Vol. 7. eds. by Hales, R. E. and Frances, A. J., American Psychiatric Press, Washington, DC, 1988

• Gelder, M. G., Clark, D. M. and Salkovskis, P.:Psychological treatment for panic disorder. J. Psychiatr. Res. (in press)

• Gelenberg, A. J.:Quality of life with clozapine. Biol. Ther, Psychiatry 14:11, 1991

• Gittelman, R. and Klein, D. F.:Relationship between separation anxiety panic and agoraphobic disorders. Psychopathology 17:15-65, 1984

• Gorman, J. M., Liebowitz, M. R., Fyer, A. J. et al.:Possible respiratory abnormalities in panic disorder. Psychopharmacol. Bull. 22:792-796, 1986

• Gorman, J. M., Liebowitz, M. R., Fyer, A. J. et al:An open trial of fluoxetine in the treatment of panic attacks. J. Clin. Psychopharmacol. 7:329-332, 1987
  pubmed

• Gorman, J. M., Battista, D., Goetz, R. R. et al.:A comparison of sodium bicarbonate and sodium lactate infusion in the induction of panic attacks. Arch. Gen. Psychiatry 46:145-150, 1989
  pubmed

• Grandi, S., Fava, G. A. and Luria, E.:Sintomi ipocondriaci nell'agorafobia [Hypochondriacal symptoms in agoraphobia]. 11th National Congress of the Italian Society of Psychosomatic Medicine (1987, Messina, Italy). Med. Psicosomatica. 33:19-27, 1988

• Gray, J.:A theory of anxiety. the role of the limbic system. Encephale 9 (suppl. 2):161B-166B, 1983

• Greden, J. F.:Anxiety or caffeinism. a diagnosis dilemma. Am. J. Psychiatry 131:1089-1092, 1974

• Griffiths, R. R, Bigelow, G. E, Liebsin, I. et al.:Drug preference in humans. doubleblind choice comparison of pentobarbital, diazepam, and placebo J. Pharmacol. Exp. Ther. 215:649-661, 1980
  pubmed

• Griffiths, R. R, McLeod, D. R, Bigelow, G. E. et al.:Relative abuse liability of diazepam and oxazepam. behavioral and sublective dose effects. Psychopharmacology (Berl.) 84:147-154, 1983

• Hamilton, M.:The assessment of anxiety states by rating. Br. J. Med. Psychol. 32:50-55, 1959
  pubmed

• Hand, I. and Wittchen, H. U. (eds):Panic and Phobias. Berlin, Springer-Verlag, 1986

• Harrison, M., Busto, U., Naranjo, C. A. et al.:Diazepam tapering in detoxification for high-dose benzodiazepine abuse. Clin. Pharmacol. Ther. 36:527-533, 1986

• Heinrichs, D. W., Hanlon, E. T. and Carpenter, W. T. Jr.:The Quality of Life Scale. an instrument for rating the schizophrenic deficit syndrome. Schizophr. Bull. 10:388-398, 1984

• Himle, J. A., Crystal, D., Curtis, G. C. et al.:Mode of onset of simple phobia subtypes. further evidence of heterogeneity. Psychiatry Res. 36:37-43, 1991
  pubmed

• Hollander, E., Liebowitz, M. R., Gorman, J. M. et al.:Cortisol and sodium lactateinduced panic. Arch. Gen. Psychiatry 46:135-140, 1989
  pubmed

• Hollander, E., Hatterer, J. and Klein, D. F.:Antidepressants for the treatment of panic and agoraphobia. In:In Handbook of Anxiety, Vol. 4. Treatment of Anxiety. eds. by Noyes, R. Jr., Roth, M. and Burrows, G. D., Elsevier, Amsterdam, Netherlands, 1990, pp. 207-231

• Hwu, H. G., Yeh, E. K. and Chang, L. Y.:Prevalence of psychiatric disorders in Taiwan defined by the Chinese diagnostic interview schedule. Acta Psychiatr. Scand. 79:136-147, 1989

• Johnston, D. G., Troyer, I. E. and Whitsett, S. F.:Clomipramine treatment of agoraphobic women. Arch. Gen. Psychiatry 45:453-459, 1988
  pubmed

• Judd, F. K., Burrows, G. D., Marriott, P. F. et al:A short-term open clinical trial of clobazam in the treatment of patients with panic attacks. Int. Clin. Psychopharmacol. 4:285-294, 1989

• Kabat-Zinn, J., Massion, A. O., Kristseller, J. et al.:Effectiveness of a meditation based stress reduction program in the treatment of anxiety disorders. Am. J. Psychiatry 149:936-943, 1992
  pubmed

• Kagan, J., Reznick, J. S., Snidman, N. et al.:Origins of panic disorder. In:Neurobiology of Anxiety. ed. by Ballenger, J. C., Alan R Liss, New York, 1990

• Kahn, R. S., Westenberg, H. G. M., Verhoeven, W. M. A. et al.:Effect of serotonin precursors and uptake inhibitor in anxiety disorders. a double-blind comparison of 5-hydroxytryptophan, clomipramine and placebo. Int. Clin. Psychopharmacol. 2:21-32, 1987

• Karabanow, O.:Double-blind controlled study in phobias and obsessions. J. Int. Med. Res. 5:42-48, 1977
  pubmed

• Katschnig, H., Pakesch, G., Loimer, N. et al.:Panic attacks and depressive symptoms in a population survey in Vienna. Pharmacopsychiatry 21:62, 1988

• Katschnig, H., Stolk, J. M., Klerman, G. L. et al.:Long-term follow-up of panic disorder, I. clinical outcomes of a large group of patients participating in an international multicenter clinical drug trial. (submitted for publication)

• Keller, M. B.:The natural history of panic disorder. In:Parper presented at the Annual meeting of the American Psychiatric Association. New Orleans, LA, May, 1991

• Keller, M. B. and Hanks, D. L.:Course and outcome in panic disorder. Prog. Neuropsychopharmacol. Biol. Psychiatry (in press)

• Klein, D. F. and Rabkin, J. G. (eds):In:Anxiety. New Research and Changing Concepts. Raven, New York, 1981

• Klerman, G. L.:Treatments for panic disorder. J. Clin. Psychiatry 53 (suppl.):14-19, 1992

• Klerman, G. L. and Lavori, P.:Drug treatment of panic disorder. comparative efficacy of alprazolam, imipramine and placebo. Br. J. Psychiatry (in press)

• Klerman, G. L., Ballenger, J. C., Burrows, G. D. et al.:The efficacy of alprazolam in panic disorder and agoraphobia. a critique of recent reports (letter). Arch. Gen. Psychiatry 46:670-672, 1989

• Lader, M. H.:Benzodiazepine withdrawal. In:Handbook of Anxiety, Vol. 4. Treatment of Anxiety. eds. by Noyes, R. Jr., Roth, M. and Burrows, G. D., Elsevier, Amsterdam, Netherlands, 1990, pp. 57-71

• Lader, M. H. and Lawson, C.:Sleep studies and rebound insomnia. methodological problems, laboratory findings, and clinical implications. Clin. Neurophamacol. 10:291-312, 1987

• Laughren, T. P., Battey, Y. W. and Greenblatt, D. J.:Chronic diazepam treatment in psychiatric outpatients. J. Clin. Psychiatry 4:461-462, 1982a

• Laughren, T. P., Battey, Y. W., Greenblatt, D. J. et al.:A controlled trial of diazepam withdrawal in chronically anxious outpatients. Acta Psychiatr. Scand. 65:171-179, 1982b

• Lesser, I. M.:Panic disorder and depression. co-occurrence and treatment. In:Clinical Aspects of Panic Disorder. ed. by Ballenger, J., Wiley-Liss, New York, 1980

• Lesser, I. M.:The relationship between panic disorder and depression. J. Anxiety Disord 2:3-15, 1988

• Lesser, I. M.:Diagnostic considerations in panic disorders. In:Handbook of Phobia Theraphy. ed. by Lindemann, C., Jason Aronson, Northvale, N. J., 1989, pp. 17-38

• Lesser, I. M. and Rubin, R. T.:Diagnostic considerations in panic disorders. J. Clin. Psychiatry 47:4-10, 1986
  pubmed

• Lesser, I. M, Rubin, R. T., Lydiard, R. B. et al:Past and current thyroid function in patients with panic disorder. J. Clin Psychiatry 48:473-476, 1987
  pubmed

• Levy, A. B.:Delirium and seizures due to abrupt alprazolam withdrawal. case report. J. Clin. Psychiatry 45:38-39, 1984
  pubmed

• Liebowitz, M. R., Fyer, A. J., Gorman, J. M. et al.:Alprazolam in the treatment of panic disorders. J. clin. Psychopharmacol 6:13-20, 1986a

• Liebowitz, M. R., Fyer, A. J., Gorman, J. et al.:Recent developments in the understanding and pharamacotherapy of panic attacks. Psychopharmacol. Bull. 22:792-796, 1986b

• Litovitz, T. L., Schmitz, B. f. and Bailey, K. M.:1989 Annual report of the American Association of Poison Control Centers National Date Collection System. Am. J. Emerg. Med. 394-430, 1990

• Lydiard, R. B., Roy-Byrne, P. P. and Ballenger, J. C.:Recent advances in the psychopharmacological treatment of anxiety disorders. Hosp. Community Psychiatry 39:1157-1165, 1988
  pubmed

• Majewska, M. D., Harrison, N. L., Schwartz, R. D. et al.:Steroid hormone metabolites are barbituate-like modulators of the GABA receptor. Science 232:1004-1007, 1986

• Marks, I. M.:Are there anticompulsive or antiphobic drugs? review of the evidence. Br. J. Psychiatry 143:338-347, 1983
  pubmed

• Marks, I. M.:In:Fears, Phobias and Rituals. Oxford University Press, New York, 1987

• Marks, I. M. and Marks, M.:Exposure treatment of agoraphobia/panic. In:Handbook Anxiety, Vol. 4. Treament of Anxiety. eds. by Noyes. R. Jr., Roth, M. and Burrows, G. D., Elsevier, Amsterdam, Netherlands, 1990, pp. 293-310

• Marks, I. M. and Swinson, R. P.:Behavioral and/or drug therapy. In:Handbook of Anxiety, Vol. 5. eds. by Burrows, G., Roth, M. and Noyes, R. Elsevier, Amsterdam, Netherlands, 1992, pp. 255-268

• Mavissakalian, M. and Dealy, R.:Pharmacological treatment of agoraphobia. imipramine vs. imipramine with programmed practice. Br. J. Psychiatry 143:348-355, 1985

• McTavish, D. and Benfield, P.:Clomipramine:an overview of its pharmacological properties and a review of its therapeutic use in obsessive compulsive disorder and panic disorder. Drugs 39:136-153, 1990

• Mellinger, G. D. and Balter, M. B.:Prevalence and patterns of use of psychotherapeutic drugs:results from a 1979 national survey of American adults. In:Epidemiological Impact of Psychotropic Drugs. Proceedings of the International Seminar on the Inpact of Psychotropic Drugs. eds. by Totnoni, G., Bellantuano, C. and Lader, M. North Holland Publishing Company, Amsterdam, Netherlands, 1981, pp. 117-135

• Mellinger, G. D., Balter, M. B., Manheimer, D. I. et al.:Psychic distress, life crisis, and use of psychotherapeutic medications. national household survey data. Arch. Gen. Psychiatry 35:1045-1052, 1978
  pubmed

• Mellinger, G. D., Balter, M. B., Uhlenhuth, E. H. et al.:Evaluating a household survey measure of psychic distress. Psychol. Med. 13:607-621, 1983
  pubmed

• Mellinger, G. D., Balter, M. B. and Uhlenhuth, E. H.:Anti-anxiety agents. duration of use and characteristics of users in the USA. Curr. Med. Res. Opin. 8 (suppl. 4):21-36, 1984

• Mellinger, G. D., Balter, M. B. and Uhlenhuth, E. H.:Insomnia and its treatment. Arch. Gen. Psychiatry 42:225-232, 1985
  pubmed

• Mellman, T. A. and Uhde, T. W.:Withdrawal syndrome with gradual tapering of alprazolam. Am. J. Psychiatry 143:1464-1466, 1986
  pubmed

• Modigh, K.:Antidepressant drugs in anxiety disorders. Acta Psychiatr. Scand. 76:57-71, 1987

• Modigh, K., Westberg, P. and Eriksson, E.:Superiority of clomipramine over imipramine in the treatment of panic disorder. a placebo-controlled trial. In:Paper presented at the 17th Congress of Collegium International Neuro-Psychopharmacologicum, Kyoto, Japan, September, 1990

• Moras, K., Craske, M. G. and Barlow, D. H.:Behavioral and cognitive therapies for panic disorder. In:Handbook of Anxiety, Vol. 4. Treatment of Anxiety. eds. by Noyes, R. Jr., Roth, N. and Burrows, G. D., Elsevier, Amsterdam, Netherlands, 1990, pp. 311-325

• Mountjoy, C. Q., Roth, M., Garside, R. F. et al.:A clinical trial of phenelzine in anxiety, depression and phobic neurosis. Br. J. Psychiatry 131:486-492, 1977
  pubmed

• Mukerji, V., Beitman, B., Alpert, M. et al.:Panic disorder. a frequent occurrence in patients with chest pain and normal coronary arteries. Angiology 38:236-240, 1987
  pubmed

• Noyes, R. Jr.:The natural history of anxiety disorders. In:Handbook of Anxiety, Vol. 1. Biological, and Cultural Perspectives. eds. by Roth, M., Noyes, R. Jr. and Burrows, G. D., Elsevier, Amsterdam, Netherlands, 1988, pp. 115-133

• Noyes, R. Jr. and Perry, P.:Maintenance treatment with antidepressants in panic disorder. J. Clin. Psychiatry 51:24-30, 1990
  pubmed

• Noyes, R. Jr., Clancy, J., Crowe, R. R. et al.:The familial prevalence of anxiety neurosis. Arch. Gen. Psychiatry 39:1057-1059, 1978

• Noyes, R., Clancy, J., Hoenck, P. R. et al.:The prognosis of anxiety neurosis. Arch. Gen. Psychiatry 37:173-178, 1980

• Noyes, R., Anderson, D. J., Clancy, J. et al.:Diazepam and propranolol in panic disorder and agoraphobia. Arch. Gen. Psychiatry 41:287-292, 1984
  pubmed

• Noyes, R. Jr., Clancy, J., Coryell, W. H. et al.:A withdrawal syndrome after abrupt discontinuation of alprazolam. Am. J. Psychiatry 142:114-116, 1985
  pubmed

• Noyes, R., Crowe, R. R., Harris, E. L. et al.:Relationship between panic disorder and agoraphobia. Arch. Gen. Psychiatry 43:227-232, 1986
  pubmed

• Noyes, R. Jr., Clancy, J., Garvey, M. J. et al.:Is agoraphobia a variant of panic disorder or a separate illness? J. Alnxiety Disord. 1:3-13, 1987a

• Noyes, R, Clarkson, C., Crowe, R. et al.:A family study of generalized anxiety disorder. Am. J. Psychiatry 144:1019-1024, 1987b

• Noyes, R. Jr., Dupont, R. L., Pecknold, J. C. et al.:Alprazolam in panic disorder and agoraphobia. results from a multicenter trial, II. patient acceptance, side effects, and safety. Arch. Gen. Psychiatry 45:423-428, 1988
  pubmed

• Noyes, R. Jr., Roth, M. and Burrows, G. D.:In:Handbook of Anxiety. Elsevier, Amsterdam, Netherlands, 1990

• Nutt, D. J., Glue, P., Lawson, C. et al.:Flumazenil provocation of panic attacks. Arch. Gen. Psychiatry 47:917-925, 1990
  pubmed

• Olfson, M. and Klerman, G. L.:The treatment of depression. prescribing practices of primary care physicians and psychiatrists. J. Fam. Pract. 35:627-635, 1992
  pubmed

• Ost, L. and Hugdahl, K.:Acquisition of agoraphobia, mode of onset and anxiety response pattern. Behav. Res. Ther. 21:623-631, 1983
  pubmed

• O'Sullivan, G. and Marks, I.:Long-term outcome of phobic and obsessive-compulsive disorders after treatment. In:Handbook of Anxiety Vol. 4. Treatment of Anxiety. eds. by Noyes, R. Jr., Roth, M. and Burrows, G. D., Elsevier, Amsterdam, Netherlands, 1990, pp. 87-108

• Parry, H. J., Balter, M. B., Mellinger, G. D. et al.:National patterns of psychotherapeutic drug use. Arch. Gen. Psychiatry 28:769-783, 1973

• Pauls, D. L., Noyes, R. Jr. and Crowe, R. R.:Familial prevalence in second-degree relatives of patients with anxiety neurosis. J. Affect. Disord. 1:279-285, 1979
  pubmed

• Petursson, H. and Lader, M.:Withdrawal from long-term benzodiazepine treatment. BMJ 283:643-645, 1981
  pubmed

• Pevnick, J. S., Jasinski, D. R. and Haertzen, C. A.:Abrupt withdrawal from therapeutically administered diazepam. Arch. Gen. Psychiatry 35:995-998, 1978
  pubmed

• Pichot, P.:History of the treatment of anxiety. In:Handbook of Anxiety od Vol. 4. Treatment of Anxiety. eds. by Noyes, R. Jr., Roth, M. and Burrows, G. D. Elsevier, Amsterdam, Netherlands, 1990, pp. 3-25

• Pollack, M. H., Tesar, G. E, Rosenbaum, J. F. et al.:Clonazepam in the treatment of panic disorder and agoraphobia. a one-year follow-up. J. Clin. Psychopharmacol. 6:302-304, 1986
  pubmed

• Pollack, M. H., Rosenbaum, J. F., Tesar, G. et al.:Clonazepam in the treatment of panic disorder and agoraphobia. Psychopharmacol. Bull. 23:141-144, 1987
  pubmed

• Pollack, M. H., Otto, M. W., Rosenbaum, J. F. et al.:Longitudinal course of panic disorder. findings from the Massachusetts General Hospital Naturalistic Study. J. Clin. Psychiatry 51:12-16, 1990
  pubmed

• Reiman, E. M.:Positron emission tomography in the study of panic disorder and anticipatory anxiety. In:Handbook of Anxiety. Vol.3. eds. by Burrows, M., Roth, M. and Noyes, R. Jr., Elsevier, Amsterdam, Netherlands, 1991, pp. 289-306

• Reiman, E. M., Raichle, M. E., Robins, E. et al.:Neuroanatomical correlates of a lactate-induced panic attack. Arch. Gen. Psychiatry 46:493-500, 1989
  pubmed

• Rickels, K.:Benzodiazepines. use and misuse. In:Anxiety New Research and Changing Concepts. eds. by Klein, D. F. and Rabkin, J. G., Raven press, New York, 1981, pp. 1-26

• Rickels, K.:Antianxiety therapy. potential value of long-term treatment. J. Clin. Psychiatry 48 (suppl.):7-11, 1987

• Rickels, K. and Schweizer, E. E.:Benzodiazepines for the treatment of panic attacks. a new look. Psychopharmacol. Bull. 2:93-99, 1986

• Rickels, K., Case, W. G., Schweizer, E. E. et al.:Low-dose dependence in Chronic benzodiazepine users. a preliminary report on 119 patients. Psychopharmacol. Bull. 22:407-415, 1986
  pubmed

• Rickels, K., Schweitzer, E., Case, W. G. et al.:Long-term therapeutic use of benzodiazepines, I. effects of abrupt discontinuation. Arch. Gen. . Psychiatry 47:899-907, 1990

• Rifkin, A., Quitkin, F. and Klein, D. S.:Withdrawal reaction to diazepam. JAMA 236:2172-2173, 1976

• Rifkin, A., Pecknold, J. C., Swinson, R. P. et al.:Sequence of improvement in agoraphobia with panic attacks. J. Psychiatry. Res. 24:1-8, 1990

• Robins, L. N., Helzer, J. E., Weissman, M. M. et al.:Lifetime prevalence of specific psychiatric disorders in three sites. Arch. Gen. Psychiatry 41:949-958, 1984
  pubmed

• Rosenbaum, J. F., Biederman, J., Gersten, J. et al.:Behavioral inhibition in children of parents with panic disorder and agoraphobia. a controlled study. Arch. Gen. Psychiatry 45:463-470, 1988

• Roth, M. and Myers, D. H.:Anxiety neuroses and phobic states. diagnosis and management. Br. Med. J. 1:559-562, 1969
  pubmed

• Roth, M., Gurney. C., Garside, R. F. et al.:Studies in the classification of affective disorders. the relationship between anxiety states and depressive illnesses. Br. J. Psychiatry 121:147-162, 1972
  pubmed

• Roy-Byrne, P., Geraci, M. and Uhde, T.:Life events and course of illness in patients with panic disorder. Am. J. Psychiatry 143:1033-1035, 1986
  pubmed

• Rubin, R. T. and Lesser, I. M.:Psychoneuroendocrinological aspects of depression, anxiety, and related disorders. Psychiatry. Fennica Supplementum 17:9-17, 1986

• Schapira, K., Roth, M., Kerr, T. A. et al.:The prognosis of affective disorders. the differentiation of anxiety states from depressive illnesses. Br. J. Psychiatry 121:175-183, 1972
  pubmed

• Schweitzer, E., Rickels, K., Case, W. G. et al.:Long-term therapeutic use of benzodiazepines, II. efficts of gradual taper. Arch. Gen. Psychiatry 47:908-915, 1990

• Senay, E. C.:Addictive behaviors and benzodiazepines, 1. abuse liability and physical dependence. Adv. Alcohol Subst. Abuse 8:107-124, 1989
  pubmed

• Sheehan, D. V.:Benzodiazepines in panic disorder and agoraphobia. J. Affect. Disord. 13:169-181, 1987
  pubmed

• Sheehan, D. V. and Raj, B. A.:Benzodiazepine treatment of panic disorder. In:Handbook of Anxiety, Vol.4. Treatment of Anxiety. eds. by Noyes, R. Jr., Roth, M. and Burrows, G. D., Elsevier, Amsterdam, Netherlands, 1990, pp. 169-206

• Sheehan, D. V., Claycomb, J. B. and Surman, O. S.:The relative efficacy of phenelzine, imipramine, alprazolam, and placebo in the treatment of painc attacks and agoraphobia. In:Paper presented at the meeting on Biology and Panic Disorders, Boston, MA, November, 1983

• Sheehan, D. V., Claycomb, J. B., Surman, O. S. et al.:Comparison of phenelzine, imipramine, alprazolam, and placebo in the treatment of panic attacks and agoraphobia. In:Paper presented at the annual meeting of the American Psychiatric Association Annual Meeting, Los Angeles, CA, May, 1984

• Siber, A.:Panic attacks facilitating recall and mastery. implications for psychoanalytic technique. J. Am. Psychonal. Assoc. 37:337-364, 1989

• Smith, D. E., Wesson, D. R. and Landry, M.:The pharmacology of benzodiazepine addiction. Fam. Pract. Recertifcation 11 (suppl.):94-106, 1989

• Solyom, C., Solyom, L., LaPierre, Y. et al.:Phenelzine and exposure in the treatment of phobias. J. Biol. Psychiatry 16:239-248, 1981

• Spitzer, R. L. and Williams, J.:Instructional Manual for the Structured Clinical Interview for DSM-III (SCID). New York Biomedical Research Department, New York State Psychiatric Institute, New York, 1985

• Stone, M. H.:Psychotherapy for the treatment of anxiety disorders. In:Handbook of Anxiety, Vol. 4. Treatment of Anxiety. eds. by Noyes, R. Jr., Roth, M. and Burrows, C. D., Elsevier, Amsterdam, Netherlands, 1990, pp. 389-404

• Sullivan, M. D., Katon, W. and Roy-Byrne, P.:Treatment of anxiety in primary care. In:Handbook of Anxiety, Vol.4. Treatment of Anxiety. eds. by Noyes, R. Jr., Roth, M. and Burrows, G. D., Elsevier, Amsterdam, Netherlands, 1990, pp. 427-448

• Torgersen, S.:Genetics of anxiety and its clinical implications. In:Handbook of Anxiety Vol. 3. The Neurobiology of Anxiety. eds. by Burrows, G. D., Roth, M. and Noyes, R. Jr., Elsevier, New York, 1991, pp. 381-406

• Tuma, A. H. and Maser, J. D.:In:Anxiety and the Anxiety Disorders. Erlbaum, Hillsdale, NJ, 1985

• Tyrer, P.:Neurosis divisible. Lancet i:685-688, 1984

• Tyrer, P.:Classification of anxiety disorders. J. Anxiety Disord. 11:991-994, 1986

• Tyrer, P. and Shawcross, C.:Monoamine oxidase inhibitors in anxiety disorders. J. Psychiatry. Res. 22 (suppl. 1):87-98, 1988

• Vollrath, M., Koch, R. and Angst, J.:The Zurich study. panic disorder and sporadic panic. symptoms, diagnosis, prevalence, and overlap with depression. Psychiatry Neurol. Sci. 239:221-230, 1990
  pubmed

• Weissman, M. M.:Panic and generalized anxiety. are they separate disorders? J. Psychiantr. Res. 24 (suppl. 2):157-162, 1990

• Weissman, M. M., Myers, J. K. and Harding, P. S.:Psychiatric disorders in a United States urban community 1975-76. Am. J. Psychiatry 135:459-462, 1978

• Wheeler, E. D., White, P. D., Reed, E. et al.:Familial incidence of neurocirculatory asthenia ("anxiety neurosis", effort syndrome"). J Clin. Invest. 27:562, 1948

• Winokur, A., Rickels, K., Greenblatt, D. J. et al.:Withdrawal reaction from longterm, low-dosage administration of diazepam. Arch. Gen. Psychiatry 37:101-105, 1980
  pubmed

• Wittchen, H. U.:Epidemiology of panic attacks and panic disorder. In:Panic and Phobias. eds. by Hand, I. and Wittchen, H. U., Springer-Verlag, New York, 1986, pp. 18-27

• Zitrin, C. M., Klein, D. F. and Woerner, M. G.:Behavior therapy, supportive psychotherapy, imipramine and phobias. Arch. Gen. Psychiatry 35:307-316, 1978
  pubmed